Maria Villalba

Pamplona, NC, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Translation of a tissue epigenetic signature to circulating free DNA suggests BCAT1 as a potential noninvasive diagnostic biomarker for lung cancer.

Translation of a tissue epigenetic signature to circulating free DNA suggests BCAT1 as a potential noninvasive diagnostic biomarker for lung cancer.

Journal: Clinical epigenetics
Published: February 23, 2022

SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation.

SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation.

Journal: Journal for immunotherapy of cancer
Published: January 12, 2021

TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients.

TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients.

Journal: Journal of clinical medicine
Published: October 09, 2019

Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1.

Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1.

Journal: Scientific reports
Published: January 11, 2019

Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machinery.

Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machinery.

Journal: Cancer letters
Published: September 26, 2018

Translating cancer epigenomics into the clinic: focus on lung cancer.

Translating cancer epigenomics into the clinic: focus on lung cancer.

Journal: Translational research : the journal of laboratory and clinical medicine
Published: March 07, 2017

miR-146a targets c-met and abolishes colorectal cancer liver metastasis.

miR-146a targets c-met and abolishes colorectal cancer liver metastasis.

Journal: Cancer letters
Published: February 17, 2017

Development of biological tools to assess the role of TMPRSS4 and identification of novel tumor types with high expression of this prometastatic protein.

Development of biological tools to assess the role of TMPRSS4 and identification of novel tumor types with high expression of this prometastatic protein.

Journal: Histology and histopathology
Published: December 21, 2016

Role of TGF-β in metastatic colon cancer: it is finally time for targeted therapy.

Role of TGF-β in metastatic colon cancer: it is finally time for targeted therapy.

Journal: Cell and tissue research
Published: December 19, 2016

Epigenetic alterations leading to TMPRSS4 promoter hypomethylation and protein overexpression predict poor prognosis in squamous lung cancer patients.

Epigenetic alterations leading to TMPRSS4 promoter hypomethylation and protein overexpression predict poor prognosis in squamous lung cancer patients.

Journal: Oncotarget
Published: December 02, 2015

TMPRSS4 induces cancer stem cell-like properties in lung cancer cells and correlates with ALDH expression in NSCLC patients.

TMPRSS4 induces cancer stem cell-like properties in lung cancer cells and correlates with ALDH expression in NSCLC patients.

Journal: Cancer letters
Published: June 28, 2015

The inhibitor of differentiation isoform Id1b, generated by alternative splicing, maintains cell quiescence and confers self-renewal and cancer stem cell-like properties.

The inhibitor of differentiation isoform Id1b, generated by alternative splicing, maintains cell quiescence and confers self-renewal and cancer stem cell-like properties.

Journal: Cancer letters
Published: July 03, 2014
Showing 1-12 of 13

Last Updated: 09/26/2026